Esketamine nasal spray compassionate use program in the Netherlands: An open label, multi-center cohort study in severe treatment-resistant depressionAbel Busz, Henricus G. Ruhé, Karin Foeken et al.|Journal of Affective Disorders Reports|2025Cited by 0